• Thu, January 23, 2025

by: MSN

Avidity Biosciences CFO sells $93,985 in stock

Michael F. MacLean, Chief Financial Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold shares of the company stock valued at approximately $93,985. The transactions occurred on January 21,

by: Forbes

S&P 500 Index Funds: Risks You Must Know Before You Invest

Low cost S&P 500 index funds are fantastic investment vehicles but they are not without risks. We discuss these risks and how to best think about them.

by: MSN

2 'Strong Buy'-Rated Dividend Stocks With Yields Above 7% for 2025

Investing in dividend stocks with a high yield of more than 7% can significantly boost your portfolio's income potential, especially in a low-interest-rate environment. However, targeting companies with sustainable dividend payouts is crucial,

by: Forbes

Is Quantum Computing Investable As The Next AI

Quantum computing has the potential of being the next big innovation. At the right size and the right price, it might even be investable.

by: MSN

Altimmune's SWOT analysis: pemvidutide potential drives stock outlook

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on developing treatments for liver disease and obesity, has been garnering attention from analysts and investors alike.

by: MSN

Diamondback Energy's SWOT analysis: stock poised for growth amid merger synergies

Diamondback Energy Inc (NASDAQ:FANG), a leading independent oil and gas company focused on the Permian Basin with a market capitalization of $51.48 billion, has been making significant strides in operational efficiency and strategic growth.

by: MSN

Are famous short-sellers going extinct? The exit of Hindenburg Research and Andrew Left shows the risky trade is shrinking

The exposé led to the company's CEO going to jail and to Anderson's short-selling firm, Hindenburg Research, becoming one of the most feared names in corporate America. When Anderson announced last Wednesday that Hindenburg was closing shop,

by: MSN

Is AbbVie Inc. (ABBV) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other halal dividend stocks.

by: MSN

Is Intel Corporation (INTC) One of the Best Socially Responsible Stocks to Buy According to Hedge Funds?

We recently compiled a list of the 8 Best Socially Responsible Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Intel Corporation (NASDAQ:INTC) stands against other best socially responsible stocks to buy according to hedge funds.
  • Fri, January 24, 2025

by: WOPRAI

Richard Hightower Maintained (MAA) at Equal with Decreased Target to $152 on, Jan 24th, 2025

by: WOPRAI

Adam Kramer Upgraded (MAA) to Overweight and Increased Target to $168 on, Jan 24th, 2025

by: WOPRAI

Arvind Ramnani Maintained (MA) at Overweight with Increased Target to $591 on, Jan 24th, 2025

by: WOPRAI

Paul Lejuez Reinstated (KR) to Neutral and Held Target at $61 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (KHC) at Hold with Decreased Target to $32 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (ITW) at Hold with Decreased Target to $266 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (ITT) at Buy with Decreased Target to $179 on, Jan 24th, 2025

by: WOPRAI

Richard Newitter Maintained (ISRG) at Buy with Increased Target to $666 on, Jan 24th, 2025

by: WOPRAI

Joanne Wuensch Maintained (ISRG) at Buy with Increased Target to $711 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (IRT) at Equal with Decreased Target to $21 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (IR) at Hold with Decreased Target to $100 on, Jan 24th, 2025

by: WOPRAI

Julien Roch Upgraded (IPG) to Overweight and Increased Target to $36 on, Jan 24th, 2025

by: WOPRAI

Adam Kramer Downgraded (INVH) to Equal and Decreased Target to $35 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (HSY) at Hold with Decreased Target to $170 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (HAIN) at Hold with Decreased Target to $7 on, Jan 24th, 2025

by: WOPRAI

Gil Luria Maintained (GOOGL) at Neutral with Increased Target to $200 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (GIS) at Buy with Decreased Target to $72 on, Jan 24th, 2025

by: WOPRAI

Matthew Akers Maintained (GE) at Overweight with Increased Target to $250 on, Jan 24th, 2025

by: WOPRAI

Ken Herbert Maintained (GE) at Outperform with Increased Target to $220 on, Jan 24th, 2025

by: WOPRAI

Terry McEvoy Reiterated (FMBH) at Equal and Held Target at $43 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (FLS) at Buy with Increased Target to $75 on, Jan 24th, 2025

by: WOPRAI

Brian Brophy Maintained (FIX) at Buy with Increased Target to $577 on, Jan 24th, 2025

by: WOPRAI

Orest Wowkodaw Maintained (FCX) at Sector with Decreased Target to $45 on, Jan 24th, 2025

by: WOPRAI

Jay Olson Downgraded (EXEL) to Perform and Decreased Target to $33 on, Jan 24th, 2025

by: WOPRAI

Jared Shaw Maintained (EWBC) at Overweight with Decreased Target to $120 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (ESS) at Equal with Decreased Target to $302 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (EQR) at Overweight with Decreased Target to $79 on, Jan 24th, 2025

by: WOPRAI

Jeffrey Bernstein Maintained (EAT) at Equal with Increased Target to $150 on, Jan 24th, 2025

by: WOPRAI

Jeffrey Bernstein Maintained (DPZ) at Underweight with Decreased Target to $402 on, Jan 24th, 2025

by: WOPRAI

Richard Shane Maintained (DFS) at Neutral with Increased Target to $169 on, Jan 24th, 2025

by: WOPRAI

Karl Shepard Maintained (DFS) at Sector with Increased Target to $210 on, Jan 24th, 2025

by: WOPRAI

Wood Lay Maintained (CWBC) at Market with Decreased Target to $22 on, Jan 24th, 2025

by: WOPRAI

Matt Breese Reiterated (CUBI) at Equal and Held Target at $58 on, Jan 24th, 2025

by: WOPRAI

Patrick Brown Reiterated (CSX) at Outperform with Decreased Target to $37 on, Jan 24th, 2025

by: WOPRAI

James McGarragle Maintained (CSX) at Sector with Decreased Target to $33 on, Jan 24th, 2025

by: WOPRAI

Brian Ossenbeck Maintained (CSX) at Overweight with Decreased Target to $37 on, Jan 24th, 2025

by: WOPRAI

Brandon Oglenski Maintained (CSX) at Overweight with Decreased Target to $38 on, Jan 24th, 2025

by: WOPRAI

Benjamin Hartford Maintained (CSX) at Outperform with Decreased Target to $38 on, Jan 24th, 2025

by: WOPRAI

Ariel Rosa Maintained (CSX) at Buy with Decreased Target to $39 on, Jan 24th, 2025

Is Quantum Computing Investable As The Next AI

Quantum computing has the potential of being the next big innovation. At the right size and the right price, it might even be investable.
The article by Vineer Bhansali for Forbes, published on January 23, 2025, discusses the investment potential of quantum computing, drawing parallels with the rise of artificial intelligence (AI). It explores whether quantum computing could be the next big technological leap following AI's transformative impact on various industries. Bhansali examines the current state of quantum computing technology, highlighting its potential to solve complex problems far beyond the capabilities of classical computers, particularly in fields like cryptography, material science, and optimization problems. The piece also addresses the challenges quantum computing faces, such as error rates, qubit stability, and the need for extremely low temperatures. Investment in quantum computing is approached with caution, noting that while the technology promises revolutionary advancements, it is still in its nascent stages with significant technical hurdles to overcome. The article suggests that while there is considerable hype, akin to the early days of AI, investors should be wary of over-enthusiasm and consider the long-term horizon for practical, scalable quantum computing solutions.

Read the Full Forbes Article at:
https://www.forbes.com/sites/vineerbhansali/2025/01/23/is-quantum-computing-investable-as-the-next-ai-/